ClinicalTrials.Veeva

Menu

The Comparison of EBUS-TBNA, TBMC Via a Tunnel, and TBFB Via a Tunnel in Diagnosing Mediastinal Lymphadenopathy.

C

China-Japan Friendship Hospital

Status

Enrolling

Conditions

Lymphadenopathy Mediastinal
Lymphadenopathy Hilar

Treatments

Procedure: EBUS-TBMC via a tunnel
Procedure: EBUS-TBNA
Procedure: EBUS-TBFB via a tunnel

Study type

Interventional

Funder types

Other

Identifiers

NCT06262620
2022-NHLHCRF-LX-01-0201-06

Details and patient eligibility

About

The goal of this prospective, multi-centre, randomised controlled clinical study is to compare the diagnostic yield and safety of the three biopsy techniques (EBUS-TBNA, EBUS-TBMC via a tunnel, and EBUS-TBFB via a tunnel) in mediastinal/hilar lymph node biopsies.

Participants will divided into EBUS-TBNA group, EBUS-TBMC via a tunnel group, and EBUS-TBFB via a tunnel group at a 1:1:1 ratio by using central, computerized random sequence, and then undertake EBUS-TBNA, EBUS-TBMC via a tunnel, or EBUS-TBFB according to the group.

Researchers will compare the diagnostic yield and incidence of adverse events of the three biopsy techniques.

Enrollment

552 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • At least 1 hilar/mediastinal lesion (short axis ≥ 1 cm) requiring diagnostic bronchoscopy procedure;
  • Patients who can understand the purpose of the trial, participate voluntarily and sign an informed consent form.

Exclusion criteria

  • The lesion is a mediastinal cyst or abscess;
  • Combined severe cardiopulmonary diseases, coagulation disorders, poor tolerance to anaesthesia, combined psychiatric disorders or severe neurosis and other relevant contraindications to bronchoscopy;
  • EBUS assessment reveals that the lesion is rich in blood flow or adjacent to a large vessel, etc. Consider biopsy to be high risk and inappropriate for continuation of biopsy;
  • EBUS did not detect lesions in the hilum and/or mediastinum;
  • Those who, in the judgement of the investigator, have poor patient compliance and are unable to complete the study as required due to mental disorders, etc.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

552 participants in 3 patient groups

EBUS-transbronchial needle aspiration
Experimental group
Description:
Participants would undertake EBUS-transbronchial needle aspiration.
Treatment:
Procedure: EBUS-TBNA
EBUS-transbronchial mediastinal cryobiopsy via a tunnel
Experimental group
Description:
Participants would undertake EBUS-transbronchial mediastinal cryobiopsy via a tunnel.
Treatment:
Procedure: EBUS-TBMC via a tunnel
EBUS-transbronchial forceps biopsy via a tunnel
Experimental group
Description:
Participants would undertake EBUS-transbronchial forceps biopsy via a tunnel.
Treatment:
Procedure: EBUS-TBFB via a tunnel

Trial contacts and locations

1

Loading...

Central trial contact

Mingming Deng, PhD; Gang Hou, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems